financetom
Business
financetom
/
Business
/
Sprinklr Fiscal Q1 Results Rise; Updates Outlook; Appoints Co-CEO -- Shares Drop
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sprinklr Fiscal Q1 Results Rise; Updates Outlook; Appoints Co-CEO -- Shares Drop
Jun 5, 2024 1:52 PM

04:38 PM EDT, 06/05/2024 (MT Newswires) -- Sprinklr ( CXM ) reported fiscal Q1 non-GAAP earnings late Wednesday of $0.09 per diluted share, up from $0.06 a year earlier.

Analysts surveyed by Capital IQ expected $0.07.

Revenue for the quarter ended April 30 was $196 million, up from $173.4 million a year earlier.

Analysts surveyed by Capital IQ expected $194.4 million.

The company said it expects fiscal Q2 non-GAAP EPS of $0.06 to $0.07. Analysts surveyed by Capital IQ expect $0.09. It expects revenue for the quarter of $194 million to $195 million. Analysts expect $196.9 million.

Sprinklr ( CXM ) raised its fiscal year 2025 non-GAAP EPS guidance to between $0.40 and $0.41 from $0.38 to $0.39 previously. Analysts expect $0.38. The company lowered revenue estimates for the year to between $779 million and $781 million from $804.5 million to $805.5 million previously. Analysts expect $805.1 million.

The company separately said that it appointed Trac Pham as co-chief executive, effective immediately. Pham most recently served as Sprinklr's ( CXM ) interim chief operating officer.

Shares of the company fell 15% in after-hours activity.

Price: 9.17, Change: -1.67, Percent Change: -15.42

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-James Flynn Reports 6.66% Stake In Singular Genomics Systems Inc As Of September 5 - SEC Filing
BRIEF-James Flynn Reports 6.66% Stake In Singular Genomics Systems Inc As Of September 5 - SEC Filing
Sep 14, 2024
Singular Genomics Systems Inc ( OMIC ): * JAMES FLYNN REPORTS 6.66% STAKE IN SINGULAR GENOMICS SYSTEMS INC AS OF SEPTEMBER 5 - SEC FILING * JAMES FLYNN - ON SEPT 5, DEERFIELD SUBMITTED NON-BINDING PROPOSAL TO SPECIAL COMMITTEE OF INDEPENDENT DIRECTORS OF SINGULAR GENOMICS SYSTEMS * JAMES FLYNN - PROPOSAL RELATES TO BUY ALL OUTSTANDING SHARES OF SINGULAR GENOMICS...
BRIEF-Vodafone Says Disagree With CMA's Provisional Findings On Vodafone/Three Merger
BRIEF-Vodafone Says Disagree With CMA's Provisional Findings On Vodafone/Three Merger
Sep 14, 2024
Sept 13 (Reuters) - Vodafone Group PLC ( VOD ): * VODAFONE GROUP PLC ( VOD ) - VODAFONE ( VOD ) & THREE RESPONSE CMA PROVISIONAL FINDINGS * VODAFONE DISAGREE WITH CMA'S PROVISIONAL FINDINGS * VODAFONE ( VOD ) - LOOK FORWARD TO WORKING WITH CMA TO SECURE APPROVAL * VODAFONE ( VOD ) : DO NOT AGREE WITH...
Nvidia's stock market dominance fuels big swings in the S&P 500
Nvidia's stock market dominance fuels big swings in the S&P 500
Sep 14, 2024
NEW YORK (Reuters) -Nvidia's huge stock rally is still exerting an outsized influence over the S&P 500 index , reinforcing concerns that broader markets could be hurt if the chipmaking giant's fortunes turn. This year's 140% surge in shares of Nvidia, whose chips are seen as the gold standard in artificial intelligence applications, has accounted for about a quarter of...
MBX Biosciences Prices $163.2 Million IPO
MBX Biosciences Prices $163.2 Million IPO
Sep 14, 2024
03:57 AM EDT, 09/13/2024 (MT Newswires) -- MBX Biosciences (MBX) said late Thursday it priced its initial public offering of 10.2 million common shares at $16 per share for expected gross proceeds of $163.2 million. The company granted the underwriters a 30-day option to buy an additional about 1.5 million shares. The shares are expected to start trading on the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved